MOLECULAR MECHANISMS OF MULTIDRUG RESISTANCE OVERCOMING BY LIPOSOMAL ANTITUMOR DRUGS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The liposomal antitumor drugs cell death induction mechanism has been analyzed in this work. Liposomal dosage forms of doxorubicin, cisplatin and aranosa overcome drug resistance. However, the mechanism of overcoming drug resistance by this drugs is different. Liposomal doxorubicin overcomes multidrug resistance by liposomes binding with the P-glycoprotein in 185 position of glycine. Liposomal cisplatin overcomes monoresistance by external apoptosis gene activation. The liposomal aranosa does not use CD95/Fas signaling pathway of apoptosis. Thus, liposomal drug action mechanism depends on the type of cells, and on the antitumor drug, that is enclosed in a liposome and can be individualized in each case.

About the authors

M. A. Baryshnikova

FSBSI «N.N. Blokhin RCRC», Moscow

Author for correspondence.
Email: ma_ba@mail.ru
Russian Federation

A. Yu. Baryshnikov

FSBSI «N.N. Blokhin RCRC», Moscow

Russian Federation

D. A. Afanasieva

FSBSI «N.N. Blokhin RCRC», Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.